Medicare Agency Further Delays SUNSET
Executive Summary
The regulation-review policy has been mired in court cases and administrative red tape since it was proposed in 2020. A new Federal Register notice pushes back implementation to 22 September at the earliest.
You may also be interested in...
SUNSET Goes Dark: HHS Withdraws Controversial Regulatory Review Rule
The US Department of Health and Human Services said the rule, which would require most regulations be reviewed every 10 years, would gobble departmental resources and could hurt the public health.
With Sun Setting On Trump Admin, HHS Finalizes Regulatory Review Rule
In a change from the draft, the final rule exempts device-specific regulations from scheduled review.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.